SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+2.97%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.24B
AUM Growth
+$1.24B
(-6.3%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-2.21%
Top 10 Holdings %
Top 10 Hldgs %
21.29%
Holding
139
New
26
Increased
28
Reduced
58
Closed
12
Top Buys
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$24.3M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$23.4M |
| 3 |
Aveanna Healthcare
AVAH
|
$20.5M |
| 4 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
$19.9M |
| 5 |
AGTI
Agiliti, Inc.
AGTI
|
$18.1M |
Top Sells
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
$32.3M |
| 2 |
Novavax
NVAX
|
$21.8M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$17.2M |
| 4 |
Arvinas
ARVN
|
$14.4M |
| 5 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$13.1M |
Sector Composition
| 1 | Healthcare | 94.02% |
| 2 | Industrials | 4.68% |
| 3 | Financials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
TG Therapeutics
TGTX
$5.03B
| $16.1M | 1.3% |
414,949
-98,700
| -19% | -$3.83M |
|
27
ResMed
RMD
$39.4B
| $16.1M | 1.3% |
65,105
-11,000
| -14% | -$2.71M |
|
|
HZNP
28
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $16M | 1.29% |
170,725
+28,250
| +20% | +$2.65M |
|
29
NeueHealth
NEUE
$60.6M
| $15.7M | 1.27% |
+912,000
| New | +$15.7M |
|
30
Align Technology
ALGN
$9.59B
| $15.5M | 1.26% |
25,425
-7,800
| -23% | -$4.77M |
|
31
Zimmer Biomet
ZBH
$20.8B
| $14.2M | 1.15% |
88,600
-31,900
| -26% | -$5.13M |
|
32
PTC Therapeutics
PTCT
$4.41B
| $14M | 1.14% |
332,291
-172,637
| -34% | -$7.3M |
|
|
NVTA
33
DELISTED
Invitae Corporation
NVTA
| $13.9M | 1.12% |
410,763
-162,996
| -28% | -$5.5M |
|
34
Olema Pharmaceuticals
OLMA
$432M
| $13.7M | 1.11% |
490,020
+477,120
| +3,699% | +$13.4M |
|
35
Alnylam Pharmaceuticals
ALNY
$58.6B
| $13.2M | 1.07% |
77,846
-31,900
| -29% | -$5.41M |
|
36
Nkarta
NKTX
$149M
| $13M | 1.05% |
410,580
+241,530
| +143% | +$7.65M |
|
37
Inspire Medical Systems
INSP
$2.53B
| $13M | 1.05% |
67,250
+6,750
| +11% | +$1.3M |
|
38
Repare Therapeutics
RPTX
$73.9M
| $12.9M | 1.04% |
412,150
+402,150
| +4,022% | +$12.5M |
|
39
Fate Therapeutics
FATE
$115M
| $12.8M | 1.03% |
147,000
+4,500
| +3% | +$391K |
|
|
ACCD
40
DELISTED
Accolade, Inc. Common Stock
ACCD
| $12.5M | 1.01% |
230,000
-240,750
| -51% | -$13.1M |
|
41
Johnson & Johnson
JNJ
$429B
| $11.9M | 0.97% |
72,500
| – | – |
|
|
42
Atea Pharmaceuticals
AVIR
$275M
| $11.6M | 0.94% |
538,884
-800,000
| -60% | -$17.2M |
|
43
UnitedHealth
UNH
$279B
| $11.5M | 0.93% |
28,800
+5,150
| +22% | +$2.06M |
|
|
JBIO
44
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $11.4M | 0.92% |
+500,000
| New | +$11.4M |
|
|
TBIO
45
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $11.4M | 0.92% |
+516,306
| New | +$11.4M |
|
46
Centene
CNC
$14.8B
| $11.2M | 0.91% |
153,975
-43,300
| -22% | -$3.16M |
|
47
Neuropace
NPCE
$310M
| $11.2M | 0.91% |
+471,966
| New | +$11.2M |
|
48
DexCom
DXCM
$30.9B
| $11.2M | 0.91% |
26,288
-5,625
| -18% | -$2.4M |
|
49
Abbott
ABT
$230B
| $10.9M | 0.88% |
93,948
+14,250
| +18% | +$1.65M |
|
|
SGEN
50
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.8M | 0.87% |
68,356
+15,950
| +30% | +$2.52M |
|